Dermtech Stock In The News

DMTK Stock  USD 0.60  0.04  6.25%   
The tone or emotional content of news articles related to DermTech can affect its prices. Positive news sentiment can lead to an increase in demand for DermTech's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of DermTech's news coverage and content from conventional and social sources shows investors' bearish mood towards DermTech. The specific impact of DermTech news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of DermTech's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using DermTech headlines in addition to utilizing other, more conventional financial analysis modules. Check out DermTech Backtesting and DermTech Hype Analysis.
For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.

DermTech Today Top News and Investor Outlook

Yahoo News
DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types
https://finance.yahoo.com/news/dermtech-announces-positive-topline-results-130500243.html
 Neutral
Yahoo News
DermTech (NASDAQ:DMTK) Will Have To Spend Its Cash Wisely
https://finance.yahoo.com/news/dermtech-nasdaq-dmtk-spend-cash-133336207.html
 Neutral
Yahoo News
DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay
https://finance.yahoo.com/news/dermtech-simplifies-dermtech-melanoma-test-130500209.html
 Neutral
Yahoo News
DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)
https://finance.yahoo.com/news/dermtech-announces-positive-topline-results-130000587.html
 Bullish
Yahoo News
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
https://finance.yahoo.com/news/dermtech-announces-inducement-grants-under-210500789.html
 Bullish
Macroaxis News: globenewswire.com
DERMTECH ALERT: Bragar Eagel & Squire, P...
https://www.globenewswire.com/news-release/2023/11/30/2788192/0/en/DERMTECH-ALERT-Bragar-Eagel-Squire-P-C-Reminds-Investors-that-a-Class-Action-Lawsuit-Has-Been-Filed-Against-DermTech-Inc-and-Encourages-Investors-to-Contact-the-Firm.html
 Neutral
Macroaxis News: globenewswire.com
ROSEN, A LEADING LAW FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DMTK
https://www.globenewswire.com/news-release/2023/11/30/2788157/673/en/ROSEN-A-LEADING-LAW-FIRM-Encourages-DermTech-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-DMTK.html
 Neutral
Macroaxis News: globenewswire.com
SHAREHOLDER ALERT: Levi & Korsinsky Notifies DermTech, Inc.(DMTK) Investors of a Class Action Lawsuit and Upcoming Deadline
https://www.globenewswire.com/news-release/2023/11/29/2788024/3080/en/SHAREHOLDER-ALERT-Levi-Korsinsky-Notifies-DermTech-Inc-DMTK-Investors-of-a-Class-Action-Lawsuit-and-Upcoming-Deadline.html
 Neutral
Macroaxis News: globenewswire.com
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DermTech, Inc. (DMTK)
https://www.globenewswire.com/news-release/2023/11/29/2787879/34548/en/Glancy-Prongay-Murray-LLP-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-Against-DermTech-Inc-DMTK.html
 Neutral
Macroaxis News: globenewswire.com
Lawsuit Deadline Alert: Investors who lo...
https://www.globenewswire.com/news-release/2023/11/28/2787279/12089/en/Lawsuit-Deadline-Alert-Investors-who-lost-over-100-000-with-shares-of-DermTech-Inc-NASDAQ-DMTK-should-contact-the-Shareholders-Foundation.html
 Neutral

DermTech Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide DermTech and other traded companies coverage. We help investors stay connected with DermTech headlines for the 23rd of April to make an informed investment decision based on correlating the impacts of news items on DermTech Stock performance. Please note that trading solely based on the DermTech hype is not for everyone as timely availability and quick action are needed to avoid losses.
DermTech's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help DermTech investors visualize upcoming and past events in order to time the market based on DermTech noise-free hype analysis.
DermTech stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the DermTech earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about DermTech that are available to investors today. That information is available publicly through DermTech media outlets and privately through word of mouth or via DermTech internal channels. However, regardless of the origin, that massive amount of DermTech data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of DermTech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of DermTech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to DermTech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive DermTech alpha.

DermTech Largest EPS Surprises

Earnings surprises can significantly impact DermTech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-08-04
2021-06-30-0.53-0.59-0.0611 
2020-05-13
2020-03-31-0.46-0.53-0.0715 
2021-03-04
2020-12-31-0.55-0.470.0814 
2023-05-04
2023-03-31-0.91-1.02-0.1112 
2021-05-13
2021-03-31-0.42-0.55-0.1330 
2022-05-03
2022-03-31-0.87-1.01-0.1416 
View All Earnings Estimates

DermTech Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to DermTech Stock. Current markets are strongly bullish. About 76% of major world exchanges and indexes are currently up. See today's market update for more information.
Investing News at Macroaxis
19th of April 2024
DermTech stock downgraded by BTIG amid strategic review
at investing.com 
Google News at Macroaxis
17th of April 2024
DermTech receives delisting warning from Nasdaq - LabPulse
at news.google.com 
businesswire News
1st of April 2024
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635
at businesswire.com 
Macroaxis News
25th of March 2024
Acquisition by Todd Wood of 85114 shares of DermTech subject to Rule 16b-3
at MacroaxisInsider 
news
8th of March 2024
Stephens Cuts DermTech Price Target to 1.50
at thelincolnianonline.com 
seekingalpha News
29th of February 2024
DermTech GAAP EPS of -0.56 in-line, revenue of 3.92M misses by 0.11M
at seekingalpha.com 
news
28th of February 2024
DermTech to Release Quarterly Earnings on Thursday
at thelincolnianonline.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DermTech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DermTech's short interest history, or implied volatility extrapolated from DermTech options trading.
When determining whether DermTech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if DermTech Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Dermtech Stock. Highlighted below are key reports to facilitate an investment decision about Dermtech Stock:
Check out DermTech Backtesting and DermTech Hype Analysis.
For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for DermTech Stock analysis

When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.09)
Revenue Per Share
0.469
Quarterly Revenue Growth
0.311
Return On Assets
(0.38)
Return On Equity
(1.06)
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.